Early-Onset Gastroesophageal Cancer: ESMO GI Oncology | September 2026

What Did the Study Find?

This meta-analysis of 45 studies, including >650,000 patients, compared adenocarcinomas of the distal esophagus, GEJ, and stomach diagnosed before age 50 with later-onset disease.

Early-onset cancers were more often advanced-stage, high-grade, and metastatic at diagnosis.

Signet-ring histology was >2-fold more common in younger patients.

Diffuse-type tumors and CDH1 alterations were enriched.

Germline pathogenic variants were approximately twice as frequent.

Conversely, MSI-high and TMB-high tumors were substantially less common in early-onset disease.

The signet-ring enrichment persisted specifically in GEJ cancers.

Why Does It Matter?

These findings suggest that early-onset gastroesophageal adenocarcinoma may represent a distinct clinicopathological and molecular phenotype, rather than merely the same disease occurring earlier.

GastroAGI Takeaway

In patients developing gastric or GEJ adenocarcinoma before age 50, clinicians should have a lower threshold for detailed family-history assessment and germline genetic evaluation, particularly when diffuse or signet-ring pathology is present. The molecular findings are important but remain practice-informing rather than treatment-changing.